Background: Conventional pacemakers and implantable cardioverter defibrillators (ICD) have high rates of lead complications. We examine the next step in modular leadless cardiac rhythm management: chronic performance of an anti-tachycardia… Click to show full abstract
Background: Conventional pacemakers and implantable cardioverter defibrillators (ICD) have high rates of lead complications. We examine the next step in modular leadless cardiac rhythm management: chronic performance of an anti-tachycardia (ATP) leadless cardiac pacemaker (LCP), commanded by a
               
Click one of the above tabs to view related content.